Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

The Effect of a New Specific Enteral Formula Compared to a Standard Formula on the Tolerability of a Combined Radio- and Chemotherapy in Cancer Patients

NCT01025167 is registered in ClinicalTrials.gov with Fresenius Kabi as lead sponsor.

NCT NCT01025167
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01025167 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
The Effect of a New Specific Enteral Formula Compared to a Standard Formula on the Tolerability of a Combined Radio- and Chemotherapy in Cancer Patients
Lead sponsor
Fresenius Kabi
Phase
Not applicable
Overall status
Completed
Start date
September 30, 2006
Completion date
January 31, 2010
Enrollment
111 (actual)
Sites
10

Conditions

As the registry lists them; a condition with its own page is linked.

enteral nutrition